Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa
Movement Disorders · 2024-01 · 39 (1) · 76-84
DOI: 10.1002/mds.29659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 07.12.2023. Verfasst von James A Brissenden und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Levodopa, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Background
Impaired movement vigor (bradykinesia) is a cardinal feature of Parkinson's disease (PD) and hypothesized to result from abnormal motivational processes—impaired motivation‐vigor coupling. Dopamine replacement therapy (DRT) improves bradykinesia, but the response to DRT is multifaceted, comprising a short‐duration response (SDR) and a long‐duration response (LDR) only manifesting with chronic treatment. Prior experiments assessing motivation‐vigor coupling in PD used chronically treated subjects, obscuring the roles of the SDR and LDR.
Methods
To disambiguate the SDR and LDR, 11 de novo PD subjects (6 male [M]:5 female [F]; mean age, 67) were studied before treatment, after an acute levodopa ( l ‐dopa) dose, and in both the practical “ off ” (LDR) and “ on ” (LDR + SDR) states after chronic stable treatment. At each visit, subjects were characterized with a standard battery including the Movement Disorder Society‐Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) and an incentivized joystick task to assess motor performance in response to varying rewards. Results l ‐Dopa induced a robust SDR and LDR, with further improvement in the combined SDR + LDR state. At baseline, after acute treatment (SDR), and after LDR induction, subjects did not exhibit the normal increase in movement speed with increasing reward. Only in the combined SDR + LDR state was there restoration of motivation‐vigor coupling.
Conclusions
Although consistent with prior results in chronically treated PD subjects, the significant improvement in motor performance observed with the SDR and LDR suggests that bradykinesia is not solely secondary to deficient modulation of motivational processes. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
- Neurology Service and Geriatric Research Education and Clinical Center, Veteran Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
ORCID-Profile: James A Brissenden
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- Parkinson's Foundation
Zitieren
APA
Brissenden, J. A., Scerbak, T., Albin, R. L., & Lee, T. G. (2024). Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa. Movement Disorders, 39(1), 76-84. https://doi.org/10.1002/mds.29659
Vancouver
Brissenden JA, Scerbak T, Albin RL, Lee TG. Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa. Movement Disorders. 2024;39(1):76-84. doi:10.1002/mds.29659
BibTeX
@article{Brissenden2024,
author = {Brissenden, James A and Scerbak, Teresa and Albin, Roger L and Lee, Taraz G},
title = {Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa},
journal = {Movement Disorders},
year = {2024},
volume = {39},
number = {1},
pages = {76--84},
doi = {10.1002/mds.29659}
}
EUVIMED